Skip to main content
SpringerLink
Log in

Juvenile Localized Scleroderma

  • Chapter
  • First Online:
Pediatric Rheumatology

Abstract

To learn about the definition, classification, presentation and management principles of localized scleroderma in children.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006;18(6):606–13.

    Article  PubMed  Google Scholar 

  2. Zulian F, Athreya BH, Laxer RM, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford). 2006;45:614–20.

    Article  CAS  Google Scholar 

  3. Zulian F, Ruperto N. Proceedings of the II° workshop on juvenile scleroderma syndrome, Padua, June 3–6, 2004.

    Google Scholar 

  4. Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J Rheumatol. 1997;24:73–80.

    CAS  PubMed  Google Scholar 

  5. Zulian F, Vallongo C, de Oliveira SKF, et al. Congenital localized scleroderma. J Pediatr. 2006;149:248–51.

    Article  PubMed  Google Scholar 

  6. Jablonska S, Blaszczyk M. Long-lasting follow-up favours a close relationship between progressive facial hemiatrophy and scleroderma en coup de sabre. J Eur Acad Dermatol Venereol. 2005;19:403–4.

    Article  CAS  PubMed  Google Scholar 

  7. Menni S, Marzano AV, Passoni E, et al. Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea. Pediatr Dermatol. 1997;14:113–6.

    Article  CAS  PubMed  Google Scholar 

  8. Blaszczyk M, Jablonska S. Linear scleroderma En coup de sabre: relationship with progressive facial hemiatrophy. Adv Exp Med Biol. 1999;455:101–4.

    Article  CAS  PubMed  Google Scholar 

  9. Sommer A, Gambichler T, Bacharach-Buhles M, et al. Clinical and serological characteristics of progressive facial hemiatrophy : a case series of 12 patients. J Am Acad Dermatol. 2006;54:227–33.

    Article  PubMed  Google Scholar 

  10. Wollina U, Buslau M, Weyers W, et al. Squamous cell carcinoma in pansclerotic morphea of childhood. Pediatr Dermatol. 2002;19:151–4.

    Article  PubMed  Google Scholar 

  11. Parodi PG, Roberti G, Draganic Stinco D, et al. Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea. Br J Dermatol. 2001;144:417–9.

    Article  CAS  PubMed  Google Scholar 

  12. Maragh SH, Davis MD, Bruce AJ, et al. Disabling pansclerotic morphea: clinical presentation in two adults. J Am Acad Dermatol. 2005;53:115–9.

    Article  Google Scholar 

  13. Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52:2873–81.

    Article  PubMed  Google Scholar 

  14. Blaszczyk M, Krolicki L, Krasu M, et al. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol. 2003;30:1997–2004.

    PubMed  Google Scholar 

  15. DeFelipe J, Segura T, Arellano JI, et al. Neuropathological findings in a patient with epilepsy and the Parry-Romberg syndrome. Epilepsia. 2001;42:1198–203.

    Article  CAS  PubMed  Google Scholar 

  16. Flores-Alvarado DE, Esquivel-Valerio JA, Garza-Elizondo M, et al. Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship? J Rheumato. 2003;30:193–5.

    Google Scholar 

  17. Holland KE, Steffes B, Nocton JJ, et al. Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics. 2006;117:132–6.

    Article  Google Scholar 

  18. Weber P, Ganser G, Frosch M, et al. Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J Rheumatol. 2000;27:2692–5.

    CAS  PubMed  Google Scholar 

  19. Guariso G, Conte S, Galeazzi F, et al. Esophageal involvement in juvenile localized scleroderma: a pilot study. Clin Exp Rheumatol. 2007;25:786–9.

    CAS  PubMed  Google Scholar 

  20. Takehara K, Sato S. Localized scleroderma is an autoimmune disease. Rheumatology (Oxford). 2005;44:274–9.

    Article  CAS  Google Scholar 

  21. Ruffatti A, Peserico A, Glorioso S, et al. Anticentromere antibody in localized scleroderma. J Am Acad Dermatol. 1986;15:637–42.

    Article  CAS  PubMed  Google Scholar 

  22. Martini G, Murray KJ, Howell KJ, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford). 2002;41:1178–82.

    Article  CAS  Google Scholar 

  23. Zulian F, Meneghesso D, Grisan E, et al. A new computerized method for the assessment of skin lesions in localized scleroderma. Rheumatology (Oxford). 2007;46:856–60.

    Article  CAS  Google Scholar 

  24. Li SC, Liebling MS, Haines KA, et al. Ultrasonography is a sensitive tool for monitoring localized scleroderma. Rheumatology (Oxford). 2007;46:1316–9.

    Article  CAS  Google Scholar 

  25. Liu P, Uziel Y, Chuang S, et al. Localized scleroderma: imaging features. Pediatr Radiol. 1994;24:207–9.

    Article  CAS  PubMed  Google Scholar 

  26. Zulian F. New developments in localized scleroderma. Curr Opin Rheumatol. 2008;20:601–7.

    Article  PubMed  Google Scholar 

  27. Cunningham BB, Landells ID, Langman C, et al. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol. 1998;39:211–5.

    Article  CAS  PubMed  Google Scholar 

  28. Kerscher M, Volkenandt M, Gruss C, et al. Low dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 1998;38:21–3.

    Article  CAS  PubMed  Google Scholar 

  29. Kreuter A, Gambichler T, Avermaete A, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol. 2001;18:241–5.

    Article  CAS  PubMed  Google Scholar 

  30. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed. 2001;17:149–55.

    Article  CAS  PubMed  Google Scholar 

  31. De Rie MA, Bos JD. Photochemotherapy for systemic and localized scleroderma. J Am Acad Dermatol. 2000;43:725–6.

    Article  PubMed  Google Scholar 

  32. El-Mofty M, Mostafa W, Esmat S, et al. Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study. Photodermatol Photoimmunol Photomed. 2004;20:93–100.

    Article  CAS  PubMed  Google Scholar 

  33. Kreuter A, Hyun J, Stucker M, et al. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54:440–7.

    Article  PubMed  Google Scholar 

  34. Staberg B, Wulf HC, Klemp P, et al. The carcinogenic effect of UVA irradiation. J Invest Dermatol. 1983;81:517–9.

    Article  CAS  PubMed  Google Scholar 

  35. Setlow RB, Grist E, Thompson K, et al. Wave-lengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A. 1993;90:6666–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Seyger MM, de Boo T, van den Hoogen FHJ, et al. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol. 1998;39:220–5.

    Article  CAS  PubMed  Google Scholar 

  37. Uziel Y, Feldman BM, Krafchik BR, et al. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr. 2000;136:91–5.

    Article  CAS  PubMed  Google Scholar 

  38. Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol. 2005;141:847–52.

    Article  CAS  PubMed  Google Scholar 

  39. Fitch PG, Retting P, Burnham JM, et al. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol. 2006;33:609–14.

    CAS  PubMed  Google Scholar 

  40. Weibel L, Sampaio MC, Visentin MT, et al. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphea) in children. Br J Dermatol. 2006;155:1013–20.

    Article  CAS  PubMed  Google Scholar 

  41. Zulian F, Martini G, Vallongo C, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2011;63(7):1998–2006.

    Article  CAS  PubMed  Google Scholar 

  42. Zulian F, Vallongo C, Patrizi A, et al. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). J Am Acad Dermatol. 2012;67(6):1151–6.

    Article  CAS  PubMed  Google Scholar 

  43. Torok KS, Arkachaisri T. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol. 2012;39(2):286–94.

    Google Scholar 

  44. Usmani N, Murphy A, Veale D, Goulden V, Goodfield M. Photochemotherapy for localized morphoea: effect on clinical and molecular markers. Clin Exp Dermatol. 2008;33(6):698–704.

    Article  CAS  PubMed  Google Scholar 

  45. Su O, Onsun N, Onay HK, et al. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma. Int J Dermatol. 2011;50(8):1006–13.

    Article  PubMed  Google Scholar 

  46. Sator PG, Radakovic S, Schulmeister K, et al. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol. 2009;60(5):786–91.

    Article  PubMed  Google Scholar 

  47. Chiu YE, Vora S, Kwon EK, Maheshwari M. A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings. Pediatr Dermatol. 2012;29(6):738–48.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Schanz S, Fierlbeck G, Ulmer A, et al. Localized scleroderma: MR findings and clinical features. Radiology. 2011;260(3):817–24.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Rheumatology Unit, Department for the Woman and Child Health, University of Padua, Via Giustiniani 3, Padua, 35128, Italy

    Francesco Zulian & Roberta Culpo

Authors
  1. Francesco Zulian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberta Culpo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Zulian .

Editor information

Editors and Affiliations

  1. Pediatric Rheumatology Division Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India

    Sujata Sawhney

  2. Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Amita Aggarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Zulian, F., Culpo, R. (2017). Juvenile Localized Scleroderma. In: Sawhney, S., Aggarwal, A. (eds) Pediatric Rheumatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-1750-6_29

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1750-6_29

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1749-0

  • Online ISBN: 978-981-10-1750-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation